Use of generic heart meds in Medicare Part D could save more than $600 million a year
How will the world decide when the pandemic is over?
9 December 2021Potential identification of SARS-CoV-2 human emergence and new COVID-19 therapeutics
9 December 2021Use of generic heart meds in Medicare Part D could save more than $600 million a year
Prescribing generic medications for heart and blood vessel diseases more frequently instead of brand-name medications in Medicare’s prescription drug program, called Part D, could save more than $600 million each year in the U.S., according to new research published today in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
